Performance and oncologic safety of sentinel lymph node biopsy after neoadjuvant chemotherapy: Results from a tertiary care center in Lebanon.
Mariam ZahweAya El SammakKarim AtayaChristelle JabbourAyman BsatBassel HafezChristine AtallahMira KheilMohamad Ali MaktabiBashar HassanVahe PanossianHazem I AssiJaber AbbasEman SbaityPublished in: Cancer medicine (2023)
The results suggest that in properly selected patients, SLNB can be feasible after NACT. Our results resemble the reported literature on accuracy of SLNB after NACT and adds to the growing pool of data on this topic.
Keyphrases
- neoadjuvant chemotherapy
- sentinel lymph node
- lymph node
- tertiary care
- locally advanced
- early stage
- end stage renal disease
- ejection fraction
- newly diagnosed
- systematic review
- rectal cancer
- prostate cancer
- peritoneal dialysis
- electronic health record
- machine learning
- robot assisted
- radical prostatectomy
- patient reported
- artificial intelligence